Phaedra Chrousos's Insider Trades & SAST Disclosures

Phaedra Chrousos's most recent trade in Vanda Pharmaceuticals Inc was a trade of 59,225 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.

Share

Note

This is a custom search result for pattern Phaedra Chrousos.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Vanda Pharmaceuticals Inc	Phaedra S. Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2025	59,225	123,350 (0%)	0%		0	Common Stock
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2024	40,202	40,202	-		-	Stock Option (right to buy)
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2024	21,887	64,125 (0%)	0%		0	Common Stock
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2023	33,960	33,960	-		-	Stock Option (Right to Buy)
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2023	17,307	42,238 (0%)	0%		0	Common Stock
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2022	24,707	24,707	-		-	Stock Option (Right to Buy)
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2022	12,006	24,931 (0%)	0%		0	Common Stock
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2021	10,000	10,000	-		-	Stock Option (Right to Buy)
Vanda Pharmaceuticals Inc	Phaedra Chrousos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2021	5,000	15,000 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades